Current management of bloodstream infections

被引：29

作者：

Rodriguez-Bano, Jesus ^{[1
,2
]}

de Cueto, Marina ^{[1
,3
]}

Retamar, Pilar ^{[1
]}

Galvez-Acebal, Juan ^{[1
,2
]}

机构：

[1] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville 41009, Spain

[2] Univ Seville, Dept Med, Seville, Spain

[3] Univ Seville, Dept Microbiol, Seville, Spain

来源：

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2010年 / 8卷 / 07期

关键词：

antimicrobial resistance; bacteremia; bloodstream infections; community-acquired infections; nosocomial infections; sepsis; COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERASE-CHAIN-REACTION; BETA-LACTAMASE PRODUCTION; KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL THERAPY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANT; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; CLINICAL-FEATURES;

D O I：

10.1586/ERI.10.49

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Bloodstream infection (BSI) is a frequent complication of invasive infections. The presence of bacteremia has therapeutic and prognostic implications. Here we review recent changes in the epidemiology, diagnosis and treatment of BSI (excluding candidemia). The evidence of the impact of healthcare-association in many community-onset episodes and the increase in drug-resistant pathogens causing BSI in the community and hospitals is reviewed. The emergence of molecular methods as an alternative tool for the diagnosis of BSI and novel aspects of clinical management, particularly of some multidrug-resistant organisms. Several quality indicators related to the diagnosis and management of bacteremia in hospitals are proposed.

引用

收藏

页码：815 / 829

页数：15

相关论文

共 155 条

[31] A Prediction Rule for Estimating the Risk of Bacteremia in Patients with Community-Acquired Pneumonia [J].

Falguera, Miquel ;

Trujillano, Javier ;

Caro, Silvia ;

Menendez, Rosario ;

Carratala, Jordi ;

Ruiz-Gonzalez, Agustin ;

Vila, Manuel ;

Garcia, Merce ;

Manuel Porcel, Jose ;

Torres, Antoni .

CLINICAL INFECTIOUS DISEASES, 2009, 49 (03) :409-416

[32] Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria [J].

Fenollar, Florence ;

Raoult, Didier .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 :S7-S15

[33] Clinical impact of an infectious disease service on the management of bloodstream infection [J].

Fluckiger, U ;

Zimmerli, W ;

Sax, H ;

Frei, R ;

Widmer, AF .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (07) :493-500

[34] Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus [J].

Fowler, Vance G., Jr. ;

Boucher, Helen W. ;

Corey, G. Ralph ;

Abrutyn, Elias ;

Karchmer, Adolf W. ;

Rupp, Mark E. ;

Levine, Donald P. ;

Chambers, Henry F. ;

Tally, Francis P. ;

Vigliani, Gloria A. ;

Cabell, Christopher H. ;

Link, Arthur Stanley ;

DeMeyer, Ignace ;

Filler, Scott G. ;

Zervos, Marcus ;

Cook, Paul ;

Parsonnet, Jeffrey ;

Bernstein, Jack M. ;

Price, Connie Savor ;

Forrest, Graeme N. ;

Faetkenheuer, Gerd ;

Gareca, Marcelo ;

Rehm, Susan J. ;

Brodt, Hans Reinhardt ;

Tice, Alan ;

Cosgrove, Sara E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07) :653-665

[35] Clinical identifiers of complicated Staphylococcus aureus bacteremia [J].

Fowler, VG ;

Olsen, MK ;

Corey, GR ;

Woods, CW ;

Cabell, CH ;

Reller, LB ;

Cheng, AC ;

Dudley, T ;

Oddone, EZ .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2066-2072

[36] Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus Bacteremia [J].

Fowler, VG ;

Justice, A ;

Moore, C ;

Benjamin, DK ;

Woods, CW ;

Campbell, S ;

Reller, LB ;

Corey, GR ;

Day, NPJ ;

Peacock, SJ .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (05) :695-703

[37] Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections [J].

Friedman, ND ;

Kaye, KS ;

Stout, JE ;

McGarry, SA ;

Trivette, SL ;

Briggs, JP ;

Lamm, W ;

Clark, C ;

MacFarquhar, J ;

Walton, AL ;

Reller, LB ;

Sexton, DJ .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (10) :791-797

[38] Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials [J].

Gardiner, David ;

Dukart, Gary ;

Cooper, Angel ;

Babinchak, Timothy .

CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) :229-238

[39] Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis:: a matched cohort study [J].

Garnacho-Montero, Jose ;

Ortiz-Leyba, Carlos ;

Herrera-Melero, Inmaculada ;

Aldabo-Pallas, Teresa ;

Cayuela-Dominguez, Aurelio ;

Marquez-Vacaro, Juan A. ;

Carbajal-Guerrero, Jesus ;

Garcia-Garmendia, Jose L. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) :436-441

[40]

Gavalda Joan, 2007, Ann Intern Med, V146, P574

← 1 2 3 4 5 6 7 8 9 10 →